1. GDF-15 and other new markers for clinical and dyastolic function in hipertrophic cardiomiopathy (HCM). Issue 1 (July 2015) Authors: Toro, R.; Sanchez, P.; Ruiz-Estevez, B.; Monsalvo, M.; Aragon, V.; Quezada, M.; Tinoco, I.; Cabeza, P.; Leal, C.; Lagares, A.; Rosety-Rodriguez, M.; Ordonez, F.; Otero, E.; Mangas, A. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GDF-15 and other new markers for clinical and dyastolic function in hipertrophic cardiomiopathy (HCM). Issue 1 (July 2015) Authors: Toro, R.; Sanchez, P.; Ruiz-Estevez, B.; Monsalvo, M.; Aragon, V.; Quezada, M.; Tinoco, I.; Cabeza, P.; Leal, C.; Lagares, A.; Rosety-Rodriguez, M.; Ordonez, F.; Otero, E.; Mangas, A. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗